好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Poster Session 02

Tuesday 04/24/12
07:30 AM - 12:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Critical Care/Emergency Neurology/Trauma, Epilepsy, Infections/AIDS/Prion Disease, MS and Related Diseases, Neural Repair/Rehabilitation
No CME available

Program Evaluations

Event Timeline
07:30 AM - 09:00 AM Break
07:30 AM - 12:00 PM Abstract 001 - Functional Outcome Measures Correlated with Strength in Becker Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 002 - Hands-Free Executive Assessment in Patients with Tetraplegia Following Acute Traumatic Spinal Cord Injury
07:30 AM - 12:00 PM Abstract 003 - A Prosthesis for Restoration of Speech in Locked-In Patients
07:30 AM - 12:00 PM Abstract 004 - Effect on Functional Brain Plasticity of a Motor Dexterity Training Carried out with and without Musical Cues: An fMRI Study of the Mirror Neuron System in Healthy Individuals
07:30 AM - 12:00 PM Abstract 005 - A Hebbian Approach to Retraining Spared Circuits after Spinal Cord Injury
07:30 AM - 12:00 PM Abstract 006 - Efficacy of Intravenous Dexamethazone for Acute Disc Herniation-Induced Sciatica
07:30 AM - 12:00 PM Abstract 007 - Pushing the Limit: A Woman with Progressive Myelopathy
07:30 AM - 12:00 PM Abstract 008 - Colonoscopic Lesions in Veterans with Spinal Cord Injury
07:30 AM - 12:00 PM Abstract 009 - Effectiveness of an Outpatient Cognitive Stimulation Program in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Diseases in Argentina: A Prospective Cohort Study
07:30 AM - 12:00 PM Abstract 010 - Quantification of Pain-Related Impairment in Subjects with Polytrauma-Induced Nervous System Disorders, According to AMA Guides Sixth Edition, and Its Correlation with Physical Performance Status
07:30 AM - 12:00 PM Abstract 011 - Expression of CD20 by Adult Neural Progenitor Cells
07:30 AM - 12:00 PM Abstract 012 - Intrathecally Transplanted Adult Neural Stem/Precursor Cells Crosstalk with Infiltrating Inflammatory Cells in Experimental Autoimmune Encephalomyelitis
07:30 AM - 12:00 PM Abstract 013 - Ex-Vivo Gene Therapy Approach for Continuous Delivery of BDNF and Its Potential Use for Neurological Disorders
07:30 AM - 12:00 PM Abstract 014 - Direct Conversion to Neurons from Adult Human Fibroblasts and Hematopoietic Stem Cells In Vitro
07:30 AM - 12:00 PM Abstract 015 - The Cytokine Profile of Human Umbilical Cord Blood
07:30 AM - 12:00 PM Abstract 016 - Pooled Short Hairpin (shRNA) Library Screen Coupled with Next-Generation Sequencing Efficiently Uncover Transcriptional Network in Neural Lineage Development of Human Embryonic Stem Cells
07:30 AM - 12:00 PM Abstract 017 - Functional Dopaminergic Neurons Derived from Human Parthenogenetic Stem Cells
07:30 AM - 12:00 PM Abstract 018 - Occipital Areas Distinguish Semantic Content in Congenitally Blind but Not Sighted Individuals
07:30 AM - 12:00 PM Abstract 019 - Electrophysiological Investigation of Fatigue in Electrical Injury Patients
07:30 AM - 12:00 PM Abstract 020 - High Prevalence of Hypovitaminosis D in Patients with Neurologic Disorders from a Rehabilitation Day-Hospital
07:30 AM - 12:00 PM Abstract 021 - Safety, Tolerability and Pharmacokinetics of the Anti-LINGO-1 Monoclonal Antibody BIIB033 in Healthy Volunteers and Subjects with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 022 - Adult-Onset Progressive Spastic Paraparesis Due to a Novel, Heteroplasmic Mitochondrial tRNAGlu (m.14685A>G) Gene Mutation
07:30 AM - 12:00 PM Abstract 023 - Effects of Ionizing Radiation on Neural Precursor Cells
07:30 AM - 12:00 PM Abstract 024 - Disengagement Neglect
07:30 AM - 12:00 PM Abstract 025 - Ipsilesional Neglect in Right Hemispace with Right Hemisphere Strokes
07:30 AM - 12:00 PM Abstract 026 - A Lateralized Brain Network for Visuospatial Attention
07:30 AM - 12:00 PM Abstract 027 - Integrity of Medial Visuomotor Pathway Predicts Better Recovery in Neglect Patients Receiving Prism Adaptation Treatment
07:30 AM - 12:00 PM Abstract 028 - Speed of Global Versus Focal Processing
07:30 AM - 12:00 PM Abstract 029 - Neuropsychological Correlates of Parietal Atrophy in Logopenic Progressive Aphasia
07:30 AM - 12:00 PM Abstract 030 - The Effects of Monocular Viewing on Verbal Versus Figural Processing during Focal Versus Global Attention
07:30 AM - 12:00 PM Abstract 031 - Automated Video Tracking To Assess Executive Aspects of Cancellation in Stroke
07:30 AM - 12:00 PM Abstract 032 - Neglect and Extinction of Kinesthesia and Thesesthesia: Cognitive and Anatomical Considerations
07:30 AM - 12:00 PM Abstract 033 - Using the Catherine Bergego Scale (CBS) in Rehabilitation of Spatial Neglect: Kessler-CBS Process
07:30 AM - 12:00 PM Abstract 034 - Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder
07:30 AM - 12:00 PM Abstract 035 - The Role of Theory of Mind in Moral Cognition among Adult Patients with Asperger Syndrome
07:30 AM - 12:00 PM Abstract 036 - Living with Balint's: A Descriptive, Narrative Account of Two Patients' Adaptations to Living with a Rare and Disabling Visuoperceptual Disorder
07:30 AM - 12:00 PM Abstract 037 - Anosognosia and Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 038 - Left Hippocampal Volume and Verbal Memory Predict Depression in Older Adults
07:30 AM - 12:00 PM Abstract 039 - Towards the Search for a Cognitive Pattern in Neuromyelitis Optica and Its Impact in Quality of Life
07:30 AM - 12:00 PM Abstract 040 - The Natural History of Anosognosia for Hemiplegia
07:30 AM - 12:00 PM Abstract 041 - Case Report: Manganese Neurotoxicity with Psychiatric Symptoms in a Patient Waiting for Liver Transplantation
07:30 AM - 12:00 PM Abstract 042 - How Behavioral and Quality of Life Changes Affect Social Cognition in Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 043 - Hospital Acquired Delirium with Myoclonus Secondary to Famotidine
07:30 AM - 12:00 PM Abstract 044 - Usefulness of a Short Form of the Pyramids and Palm Trees Test To Differentiate Variants of Primary Progressive Aphasia
07:30 AM - 12:00 PM Abstract 045 - Quantifying Fluency of Connected Speech with a Brief Protocol in Primary Progressive Aphasia
07:30 AM - 12:00 PM Abstract 046 - Neuroanatomical Correlates of Error Rates on a Object Semantics Test
07:30 AM - 12:00 PM Abstract 047 - Parkinsonism in the Agrammatic and Logopenic Variants of Primary Progressive Aphasia
07:30 AM - 12:00 PM Abstract 048 - Differentiating Primary Progressive Aphasias in a Brief Sample of Connected Speech
07:30 AM - 12:00 PM Abstract 049 - Dynamics of Semantic Recall in Younger and Older Adults
07:30 AM - 12:00 PM Abstract 050 - A Transient Loss of British Charm: A Case of Foreign Accent Syndrome and Proposed Neuroanatomical Pathway
07:30 AM - 12:00 PM Abstract 051 - Aphasia in Neurodegenerative Diseases: Can Language Impairment Predict the Underlying Pathology ?
07:30 AM - 12:00 PM Abstract 052 - Thematic Role Density Impairs Action Verb Comprehension in Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 053 - Sex-Linked & Handedness Effects: Do Temporal-Parietal Asymmetry Patterns Diverge in Adults Who Stutter?
07:30 AM - 12:00 PM Abstract 054 - Integrating Social Cognition Measures with Neuropsychological Testing
07:30 AM - 12:00 PM Abstract 055 - Comparison of Cerebrospinal Fluid Levels of Tau and A[beta]1-42 in Alzheimer's Disease and Frontotemporal Degeneration Using Two Analytical Platforms
07:30 AM - 12:00 PM Abstract 056 - Inflammation Is Related to Corpus Callosum Integrity and Executive Functions in Healthy Older Adults
07:30 AM - 12:00 PM Abstract 057 - Does Dementia Associated with Vitamin B12 Deficiency Respond to Treatment?
07:30 AM - 12:00 PM Abstract 058 - Plasma n-3 PUFAs, Cognitive Decline, and White Matter Mediation
07:30 AM - 12:00 PM Abstract 059 - Vitamin B12 and Neurological Function: Is There a Threshold Level?
07:30 AM - 12:00 PM Abstract 060 - Production and Characterization of High Affinity Rabbit Monoclonal Antibodies (RmAbs) to Amyloid [beta]38 (A[beta]38) Peptide
07:30 AM - 12:00 PM Abstract 061 - Systemic Inflammatory Markers, Cognition and Brain Structure among Cognitively Normal Elderly
07:30 AM - 12:00 PM Abstract 062 - Stability of Plasma Antibody Signature in Elderly Individuals with or without Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 063 - Cystatin C Predicts Changes in Brain Structure and Cognition in the Elderly
07:30 AM - 12:00 PM Abstract 064 - Plasma Vitamin D, Cognitive Function, and Cerebrospinal Fluid Biomarkers in Subjects at Risk of Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 065 - CNS Live Imaging Reveals a New Mechanism of Myelination: The Liquid Croissant Model
07:30 AM - 12:00 PM Abstract 066 - Multiple Sclerosis: Selective Deregulation of microRNA Biogenesis in B Cells
07:30 AM - 12:00 PM Abstract 067 - An Overlap in the Humoral Immune Response by NMO and MS Patients That Is Distinct from Patients with Other Neurological Diseases
07:30 AM - 12:00 PM Abstract 068 - Oxidative Stress Imbalance in Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 069 - Elevated Thyroid Peroxidase Antibodies as an Indicator of Increased Thyroid Autoimmunity among Multiple Sclerosis Patients in the Postpartum Setting
07:30 AM - 12:00 PM Abstract 070 - Laquinimod Treatment Enhances Callosal Conduction in a Chronic Mouse Model of Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 071 - Monitoring Free and Cell-Bound Natalizumab in CSF and Blood in Natalizumab-Treated MS Patients
07:30 AM - 12:00 PM Abstract 072 - Effects of Natalizumab on the B-Cell Frequency and the Cytokine Expression in Blood
07:30 AM - 12:00 PM Abstract 073 - Multiple Sclerosis Patients Treated with IFNB-1b Express a Unique Isoform of the Oxidation Resistance Protein NCOA7
07:30 AM - 12:00 PM Abstract 074 - Metalloproteinase-Disintegrins in MS Patients and Their Regulation by Interferon-beta
07:30 AM - 12:00 PM Abstract 075 - The Specificity of the Antibody Response to Epstein-Barr Virus Is Altered in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 076 - Quantification of EBNA-1-Specific CD8+ T-Cells in Cerebrospinal Fluid and Peripheral Blood of Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 077 - Adipokine Levels in Relapsing and Progressive Forms of Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 078 - Leptin Levels in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 079 - Serum Concentrations of Resistin, Leptin and Adiponectin in Multiple Sclerosis and Myasthenic Patients Are Independent from Insulin Resistance
07:30 AM - 12:00 PM Abstract 080 - A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up?
07:30 AM - 12:00 PM Abstract 081 - Flow Cytometric Immunophenotyping of the Blood and CSF of Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 082 - Neuroketals in the Cerebrospinal Fluid of Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 083 - Increased IL-27 Cytokine Levels in the Cerebrospinal Fluid but Not in the Blood of Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 084 - Astrocyte-Derived VEGF-A Drives Blood-Brain Barrier Disruption, Lymphocyte Infiltration and Neuropathology in Inflammatory and Demyelinating CNS Disease
07:30 AM - 12:00 PM Abstract 085 - Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 086 - IFNbeta-1b Treatment Alters the Composition of Circulating B Cell Subsets, in Particular Reducing the Number of Autoantibody Secreting B1 Cells in Patients with Relapsing-Remitting Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 087 - Differential Immunological Changes in Peripheral and CNS Compartments during Fingolimod Therapy in MS
07:30 AM - 12:00 PM Abstract 089 - Association of Targeted Blood Biomarkers with Interferon Beta-1a Treatment Administration, Magnetic Resonance Imaging Activity, and Treatment Response
07:30 AM - 12:00 PM Abstract 090 - Fingolimod Reduces Circulating CD4+ Counts in Patients with Relapsing Multiple Sclerosis (RMS)
07:30 AM - 12:00 PM Abstract 091 - Immunological Markers Network Investigated with a Novel Mathematical Approach in Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 092 - gMS-Classifier1 Serum Assay Is Associated with Faster Relapsing-Remitting Multiple Sclerosis (RRMS) Disability Progression, Reaching Expanded Disability Status Scale (EDSS) ? 4.0 - A Retrospective Analysis
07:30 AM - 12:00 PM Abstract 093 - Comparison of Serum and Various Types of Plasma from Multiple Sclerosis Patients for Biomarker Studies
07:30 AM - 12:00 PM Abstract 094 - Molecular Subtypes of Relapsing Multiple Sclerosis Can Be Distinguished by Whole Blood Transcriptome Analysis
07:30 AM - 12:00 PM Abstract 095 - Do Immunological Profiles of the Cerebrospinal Fluid Correlate with Disease Severity in Multiple Sclerosis?
07:30 AM - 12:00 PM Abstract 096 - EBV, CMV, and HSV IgG Titers Are Not Predictive of Subsequent Relapse Risk in Pediatric Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 097 - Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 098 - Identification of Immunophenotypic Signatures in the Innate Immune System of MS Patients by Multiparametric Flow Cytometry
07:30 AM - 12:00 PM Abstract 099 - Relapse Related Differentially Expressed microRNA May Have a Role in Immunological Processes in MS
07:30 AM - 12:00 PM Abstract 100 - Characterisation of Dendritic Cell Subsets in Lymph Nodes of Multiple Sclerosis Patients Treated with Transdermally Delivered Myelin Peptides
07:30 AM - 12:00 PM Abstract 101 - Characterization of Blood-Derived Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Multiple Sclerosis (MS) Patients, Healthy Controls, and Systemic Lupus Erythematosus (SLE) Patients
07:30 AM - 12:00 PM Abstract 102 - Relation of Myelin Ingestion with Distinct Polarization Properties of Human Adult Microglia Versus Blood-Derived Macrophages
07:30 AM - 12:00 PM Abstract 103 - A New Method for Diagnosing Multiple Sclerosis: Use of 454 Sequencing To Identify Somatic Hypermutation Frequency in B Cells from Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 104 - Evaluation of Anti-Glycan Antibody Status in Relationship to Disease Parameters and as a Tool To Assist the Diagnosis of MS
07:30 AM - 12:00 PM Abstract 105 - Laquinimod Promotes T Cell Immune Modulation in Central Nervous System Autoimmunity Via Type II (M2) Myeloid APC
07:30 AM - 12:00 PM Abstract 106 - Treatment with Oral Laquinimod Augments the In Situ Expression of Brain-Derived Neurotrophic Factor and Reduces CNS Injury
07:30 AM - 12:00 PM Abstract 107 - Fingolimod Treatment Is Associated with a Down-Modulation of S1P1 Receptor Protein in the CNS
07:30 AM - 12:00 PM Abstract 108 - Dimethyl Fumarate Suppresses Inflammation In Vitro Via Both Nrf2-Dependent and Nrf2-Independent Pathways
07:30 AM - 12:00 PM Abstract 109 - Glatiramer Acetate Mediated Expression of [alpha]4[beta]1integrin (VLA-4) on T and B Regulatory Cells in EAE Mice
07:30 AM - 12:00 PM Abstract 110 - Prolonged Incubation with Laquinimod Protects Hippocampal Cells from Oxidative Stress
07:30 AM - 12:00 PM Abstract 111 - Laquinimod Restricts Inflammatory Gene Expression in a Human Model of Reactive Astrogliosis
07:30 AM - 12:00 PM Abstract 112 - Fingolimod Treatment Reduces Circulating CD4+ Regulatory T Cells and Th17 Cells in Blood of Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 113 - Interferon-[beta] Induces Hepatocyte Growth Factor in Peripheral Blood Monocytes of Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 114 - Natalizumab Treatment Effects Sustained Decrease in Serum Levels of Fibronectin and Soluble Adhesion Molecules sVCAM-1 and sICAM-3
07:30 AM - 12:00 PM Abstract 115 - Analysis of Laquinimod Efficiency during Experimental Autoimmune Encephalomyelitis
07:30 AM - 12:00 PM Abstract 116 - Laquinimod-Mediated Modulation of B Cells from Multiple Sclerosis Patients: Affecting Direct and Indirect Immune-Regulatory Functions
07:30 AM - 12:00 PM Abstract 117 - Laquinimod Treatment Reduces an Immunogenic Dendritic Cell Population and Protects from Autoimmune CNS Inflammation
07:30 AM - 12:00 PM Abstract 118 - Effects of Laquinimod on the Human Blood-Brain Barrier
07:30 AM - 12:00 PM Abstract 119 - Alemtuzumab (Anti-CD52 mAb) Induces Expansion of Treg and Th2 Cells and Inhibits Th1 and Th17 Cells in Treated Patients with Relapsing Remitting Multiple Sclerosis (RRMS)
07:30 AM - 12:00 PM Abstract 120 - Dimethylfumarate Protects from Oxidative Stress by Increasing Glutathione
07:30 AM - 12:00 PM Abstract 121 - Neuroprotective Effects of BG-12 on Malonate-Induced Striatal Lesion Volume in Sprague-Dawley Rat Brain
07:30 AM - 12:00 PM Abstract 122 - The Effect of Fingolimod on Peripheral Blood Mononuclear Cell Phenotypes: A Prospective Study
07:30 AM - 12:00 PM Abstract 123 - Toll-Like Receptors as Genes Regulated by Interferon-beta and Their Role in Multiple Sclerosis Therapy
07:30 AM - 12:00 PM Abstract 124 - MicroRNA Expression Changes in Response to Interferon-beta-1b Therapy in Blood Cells of Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 125 - CSF Free Kappa Chains Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndromes
07:30 AM - 12:00 PM Abstract 126 - B Cells and Subsets in Pediatric-Onset Relapsing-Remitting Multiple Sclerosis: Similarities and Differences to Adult-Onset Disease
07:30 AM - 12:00 PM Abstract 127 - The Role of Prolactin on B Cell Regulation in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 128 - Cerebrospinal Fluid Derived from Progressive Multiple Sclerosis Patients Stimulates Differentiation of Neural Precursor Cells In Vitro
07:30 AM - 12:00 PM Abstract 129 - Neural and Immune-Related Molecules in Cerebrospinal Fluid (CSF) of Pediatric-Onset Acquired Demyelinating Syndromes (ADS) of the CNS: Differential Expression in Children Subsequently Diagnosed with Multiple Sclerosis vs. Monophasic Disease
07:30 AM - 12:00 PM Abstract 130 - NMO-IgG as Measured in Multiple Facilities in Optic Neuritis (ON), Transverse Myelitis (TM) and Combinations Thereof
07:30 AM - 12:00 PM Abstract 131 - B Cell Epitope Mapping of Aquaporin-4 (AQP4) and Reactivity to AQP4 Epitopes in Neuromyelitis Optica (NMO) and Relapsing-Remitting Multiple Sclerosis (RRMS)
07:30 AM - 12:00 PM Abstract 132 - The Effect of NMO-IgG and Complement Against Primary Human Astrocytes in Culture
07:30 AM - 12:00 PM Abstract 133 - Highly Sensitive Radioimmunoassay Identifies Anti-Aquaporin-4 Autoantibodies in Several "Seronegative" Patients Suspected for Neuromyelitis Optica-Spectrum Disorders (NMO)
07:30 AM - 12:00 PM Abstract 134 - Aquaporin-4 Peptide-Specific T Cells Induce CNS Inflammation
07:30 AM - 12:00 PM Abstract 135 - Efficacy, Safety and JC-Antibody Prevalence Following Natalizumab Treatment for 36 Month and More in Patients with Relapsing Remitting Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 136 - Disappearance of Cerebrospinal Fluid Oligoclonal Bands after Natalizumab Treatment of Multiple Sclerosis Patients
07:30 AM - 12:00 PM Abstract 137 - Anti-JC Virus Antibodies in a Large German Natalizumab-Treated Multiple Sclerosis Cohort
07:30 AM - 12:00 PM Abstract 138 - Epidemiology of Anti-JCV Antibodies in Israeli Multiple Sclerosis Population
07:30 AM - 12:00 PM Abstract 139 - Anti-JC Virus Antibody Titer Changes during Natalizumab Treatment in a Swedish MS Cohort
07:30 AM - 12:00 PM Abstract 140 - JCV Antibody Status: Patient Decision Making and Clinical Course
07:30 AM - 12:00 PM Abstract 141 - Anti-JCV Antibody Prevalence in a French Cohort of MS Patients under Natalizumab
07:30 AM - 12:00 PM Abstract 142 - Differential Increase of Circulating Haematopoietic Stem Cells (HSC) Following Therapeutic alpha 4-Integrin Blockade in Multiple Sclerosis: Correlation between HSC Mobilization Status and Response to Treatment
07:30 AM - 12:00 PM Abstract 143 - Effect of Teriflunomide on the Viral Load and Anti-Viral Antibody Responses in the Theiler's Virus Model of MS
07:30 AM - 12:00 PM Abstract 144 - Serum Levels of Soluble Adhesion Molecules Remain Stable during Short- and Long-Term Interferon-beta-1b Treatment
07:30 AM - 12:00 PM Abstract 145 - Differential Diagnosis of Adult-Onset Chronic Myelopathy: MRI-Based Approach
07:30 AM - 12:00 PM Abstract 146 - Moyamoya Disease Can Masquerade as Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 147 - The Co-Occurrence of MS and ALS: Chance or Shared Biology?
07:30 AM - 12:00 PM Abstract 148 - Neurosarcoidosis of Spinal Cord - Clinico-Radiologic Correlation of 26 Cases
07:30 AM - 12:00 PM Abstract 149 - Clinical, Imaging and Histopathological Features of Adult Onset Leukoencephalopathy with Neuroaxonal Spheroids and Pigmented Glia: A Report of 4 Cases
07:30 AM - 12:00 PM Abstract 150 - White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?
07:30 AM - 12:00 PM Abstract 151 - Chronic Relapsing Inflammatory Optic Neuropathy: A Differential Diagnosis from Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 152 - Antiphospholipid Antibodies in the Initial Evaluation of Suspected Multiple Sclerosis Seem To Have Different Meanings
07:30 AM - 12:00 PM Abstract 153 - Do We Need Broad Immunological Work-Up in All Patients with CIS?
07:30 AM - 12:00 PM Abstract 154 - Correlation between Antiphospholipid Antibodies and Epilepsy: A Systematic Review
07:30 AM - 12:00 PM Abstract 155 - Primary Antiphospholipid Antibody Syndrome Manifesting as Refractory Partial Status Epilepticus Unrelated to a Structural Brain Abnormality
07:30 AM - 12:00 PM Abstract 156 - Glutamate and the Pathogenesis of Glutamic Acid Decarboxylase Antibody Associated Epilepsy
07:30 AM - 12:00 PM Abstract 157 - Clinical Spectrum and Course in Individuals with Adult-Onset Medically-Intractable Epilepsy and Anti-GAD Antibody
07:30 AM - 12:00 PM Abstract 158 - Anti-NMDA Receptor Encephalitis Presenting as Partial Seizures with Delayed Onset of Mood Disturbance
07:30 AM - 12:00 PM Abstract 159 - Vague and Nonspecific Symptoms in Patients with Concern for Epilepsy - A Benign Phenomenon or a Manifestation of Seizure Activity?
07:30 AM - 12:00 PM Abstract 160 - Injury Occurrence in the Epilepsy Monitoring Unit: Psychogenic Nonepileptic Versus Epileptic Seizures
07:30 AM - 12:00 PM Abstract 161 - Electroencephalographic Correlation in Postanoxic Mycolonus: A Case Series
07:30 AM - 12:00 PM Abstract 162 - Usefulness of Ambulatory EEG Immediately Following Inpatient EEG-Video
07:30 AM - 12:00 PM Abstract 163 - Diagnostic Yield as a Quality Measure in the Epilepsy Monitoring Unit
07:30 AM - 12:00 PM Abstract 164 - Postictal Nose-Wipe in Localization of Bitemporal Lobe Seizures
07:30 AM - 12:00 PM Abstract 165 - The Pleomorphism of Electroencephalogram in Non Convulsive Status Epilepticus
07:30 AM - 12:00 PM Abstract 166 - Treatment Approaches in Non-Convulsive Status Epilepticus
07:30 AM - 12:00 PM Abstract 167 - Sleep/Wake and Diurnal Variations of Seizure Evolution in Pediatric Patients
07:30 AM - 12:00 PM Abstract 168 - Descriptive Analysis of the Posture and Movement in Psychogenic Non-Epileptic Seizures
07:30 AM - 12:00 PM Abstract 169 - Tilt Table Test & Misdiagnosis of Epilepsy
07:30 AM - 12:00 PM Abstract 170 - Primary Myoclonus-Dystonia: A Diagnosis Often Missed in Children
07:30 AM - 12:00 PM Abstract 171 - Detection of Anti-Folate Receptor Antibodies in the Serum and CSF of Cerebral Folate Deficiency Patients
07:30 AM - 12:00 PM Abstract 172 - Episodic Leukoencephalopathy Due to Novel Mitochondrial Complex I NDUFV1 Gene Mutations
07:30 AM - 12:00 PM Abstract 173 - Infantile Spasms and Hypsarrhythmia in a Child with Isolated Sulfite Oxidase Deficiency
07:30 AM - 12:00 PM Abstract 174 - Case of Infantile-Onset SCA-5 and a Novel SPTBN2 Mutation
07:30 AM - 12:00 PM Abstract 175 - Intracranial Optic Nerve Enlargement in Infantile Krabbe's Disease
07:30 AM - 12:00 PM Abstract 176 - Frequency of Urinary Complications in Children Treated with a Traditional Ketogenic Diet
07:30 AM - 12:00 PM Abstract 177 - Trihexyphenidyl Has Cognitive Side Effects in Children with DYT1 Dystonia
07:30 AM - 12:00 PM Abstract 178 - Seizures Presenting as Apnea in Near Term Neonates
07:30 AM - 12:00 PM Abstract 179 - Balint Syndrome in the Pediatric Population: A Case Report of Three Patients
07:30 AM - 12:00 PM Abstract 180 - Neonatal Radial Nerve Palsy
07:30 AM - 12:00 PM Abstract 181 - MRI Findings with Duplication of 17q12 Chromosome Region in a 17 Year Old
07:30 AM - 12:00 PM Abstract 182 - Coated-Platelet Levels Are Associated with Hypertension in Patients with Transient Ischemic Attack
07:30 AM - 12:00 PM Abstract 183 - Risk Factors Associated with 30-Day Readmission Vary among Stroke Subtypes
07:30 AM - 12:00 PM Abstract 184 - Varaiance in Interpretation and Treatment Choices among Physicians in Patients with Stroke and Advanced Health Care Directives
07:30 AM - 12:00 PM Abstract 185 - Coated-Platelet Levels and Cerebral Microbleeds in Patients with Non-Lacunar Brain Infarction
07:30 AM - 12:00 PM Abstract 186 - Using Standardized Web Based Tests in Clinical Trials To Improve Investigator and Coordinator Protocol Familiarity: Experience from Antihypertensive Treatment of Acute Cerebral Hemorrhage II Trial
07:30 AM - 12:00 PM Abstract 187 - GIS Analysis of Access to VA Acute Stroke Care
07:30 AM - 12:00 PM Abstract 188 - Cerebral Air Embolism with Upper Endoscopy: Two Patients, Three Events
07:30 AM - 12:00 PM Abstract 189 - Carotid Artery Disease Influences the Severity of White Matter Hyperintensity in Patients with Acute Lacunar Infarcts
07:30 AM - 12:00 PM Abstract 190 - Pulmonary Arteriovenous Fistula (P-AVF): A Rare but an Important Cause of Stroke
07:30 AM - 12:00 PM Abstract 191 - Isolated Hand Paralysis Due to Stroke in Precentral Knob Region
07:30 AM - 12:00 PM Abstract 192 - Intravenous Thrombolysis in 3-4.5 Hours: Utilization and Outcomes - Analysis of the Minnesota Stroke Registry
07:30 AM - 12:00 PM Abstract 193 - CT Angiography and Perfusion Studies Do Not Significantly Prolong the Door-to-Needle Times for Acute Stroke Patients Treated with Intravenous Thrombolytics
07:30 AM - 12:00 PM Abstract 194 - A Regional Assessment of Mismatch between Joint Commission Certified Stroke Centers and Population Requirements
07:30 AM - 12:00 PM Abstract 195 - Intravenous Thrombolysis Administered by Vascular vs. Non-Vascular Neurologists in a Statewide Telestroke Network
07:30 AM - 12:00 PM Abstract 196 - Extending Therapeutic Window for Intravenous Thrombolysis to 4.5 Hours Remains Safe and Effective in Asian Acute Ischemic Stroke Patients
07:30 AM - 12:00 PM Abstract 197 - Antihypertensive Medication in Suspected Stroke Patients in Pre-Hospital Settings in United States
07:30 AM - 12:00 PM Abstract 198 - Admission Leukocytosis Is Not Associated with Early Response to Tissue Plasminogen Activator in Patients with Acute Ischemic Stroke
07:30 AM - 12:00 PM Abstract 199 - Off-Label Use of Intravenous t-PA May Be Safe in Select Patients
07:30 AM - 12:00 PM Abstract 200 - Hyperacute Stenting for Acute Ischemic Stroke Is Associated with a High Rate of Symptomatic Intracranial Hemorrhage
07:30 AM - 12:00 PM Abstract 201 - Clinical and Radiological Presentation of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus
07:30 AM - 12:00 PM Abstract 202 - High Risk of Symptomatic Vasospasm in Unaffected Arteries in Subarachnoid Hemorrhage Patients Receiving Targeted Endovascular Treatment for Focal Symptomatic Vasospasm
07:30 AM - 12:00 PM Abstract 203 - Outcomes of Transferred Versus Direct-Admit Hemorrhagic Stroke Patients at a Large Comprehensive Stroke Center
07:30 AM - 12:00 PM Abstract 204 - Factors Associated with Early Neurologic Deterioration after Primary Intracerebral Hemorrhage: A Systematic Review of the Literature
07:30 AM - 12:00 PM Abstract 205 - Subarachnoid Hemorrhage with Severe Vasospasm after Bevacizumab Therapy: A Case Report
07:30 AM - 12:00 PM Abstract 206 - Resumption of Antithrombotic Therapy Following Hemorrhagic Stroke in Patients with Atrial Fibrillation
07:30 AM - 12:00 PM Abstract 207 - Higher Body Mass Index Predicts Better Outcomes after Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 208 - Delayed Asystole in a Patient with Aneurysmal Subarachnoid Hemorrhage Triggered by Surgical Intervention
07:30 AM - 12:00 PM Abstract 209 - Outcome Differences in Patients Transferred from Referring Hospital Emergency Department with Intracerebral Hemorrhage Versus Another Medical-Surgical Illness: A Case Controlled Study
07:30 AM - 12:00 PM Abstract 210 - Influence of Urine Output on Magnesium Level in Aneurysmal Subarachnoid Hemorrhage
07:30 AM - 12:00 PM Abstract 211 - Risk Factors and Long Term Outcome in Young Adults with Spontaneous Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 212 - Serial FOUR Score and Glasgow Coma Score in Critically Ill Medical Patients: Relation to Outcome
07:30 AM - 12:00 PM Abstract 213 - Implementation of a Model of Robotic-Telepresence (RTP) in the Neuro ICU and Effect on Critical Care Team Satisfaction
07:30 AM - 12:00 PM Abstract 214 - Effect of Testing Environment on Pre-Participation Reaction Time in High School Athletes
07:30 AM - 12:00 PM Abstract 215 - Virtual Family Meetings in the ICU Setting
07:30 AM - 12:00 PM Abstract 216 - Epidemiological Trends of Adult Respiratory Distress Syndrome (ARDS) after Traumatic Brain Injury in the United States
07:30 AM - 12:00 PM Abstract 217 - Prevalence of Depression and Anxiety Symptoms among Families of Survivors in a Neurosciences Intensive Care Unit
07:30 AM - 12:00 PM Abstract 218 - The Impact of a Neurohospitalist Service on Patient and 好色先生al Outcomes at an Academic Medical Center
07:30 AM - 12:00 PM Abstract 219 - Evaluating Pain, Sedation and Delirium in the Neurologically Critically Ill
07:30 AM - 12:00 PM Abstract 220 - Comparison between Institutionally-Defined Clinical Criteria and CDC-Criteria for the Diagnosis of Ventriculostomy-Related Infection
07:30 AM - 12:00 PM Abstract 221 - Accuracy of Stroke Identification by EMS Dispatch Units: An Analysis of National Emergency Medical Services Information System Data (NEMSIS)
07:30 AM - 12:00 PM Abstract 222 - Significance of Admission Arterial Hyperoxia in Critically-Ill Stroke Patients
07:30 AM - 12:00 PM Abstract 223 - A National Assessment of Factors Influencing Emergency Medical Services Times among Acute Stroke Patients
07:30 AM - 12:00 PM Abstract 224 - Increased Hemoglobin A1c Level Is Associated with a Better Outcome in Patients with Spontaneous Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 225 - Neuroprotective Role of Endogenous Serum Magnesium on the Severity of Spontaneous Intraparenchymal Hemorrhage
07:30 AM - 12:00 PM Abstract 226 - A Case of Cerebral Venous Thrombosis in the Setting of Romiplostim Use
07:30 AM - 12:00 PM Abstract 227 - Predictors of Hemorrhage Volume and Disability after Perimesencephalic Subarachnoid Hemorrhage
07:30 AM - 12:00 PM Abstract 228 - A Low Threshold Needed To Diagnose and Treat NMDA Receptor Antibody Associated Limbic Encephalitis
07:30 AM - 12:00 PM Abstract 229 - Successful Immunoglobulin Desensitization after Anaphylactic Shock in a Patient with Chronic Inflammatory Demyelinating Polyneuropathy
07:30 AM - 12:00 PM Abstract 230 - Is Migraine Headache Associated with Concussion in Athletes? A Case-Control Study
07:30 AM - 12:00 PM Abstract 231 - Dopaminergic Substitution Therapy after Subthalamic Deep Brain Stimulation: An Open Label Randomized Multicentric Controlled Trial
07:30 AM - 12:00 PM Abstract 232 - Long-Term Neuropsychological Outcomes of Staged Subthalamic Nuclei Stimulation in Patients with Parkinson's Disease
07:30 AM - 12:00 PM Abstract 233 - Analysis of Stereotactic Accuracy in Patients Undergoing Deep Brain Stimulation Using Nexframe and Leksell Frame
07:30 AM - 12:00 PM Abstract 234 - Subthalamic Deep Brain Stimulation Modulates Small-Fiber Dependent Sensory Thresholds in Parkinson's Disease
07:30 AM - 12:00 PM Abstract 235 - Low Frequency Repetitive Deep Transcranial Magnetic Stimulation Improves Motor Performance in Patients with Parkinson's Disease
07:30 AM - 12:00 PM Abstract 236 - Effects of Bilateral Subthalamic Nucleus Deep Brain Stimulation on Impulse Control and Repetitive Behavior Disorders in Parkinson's Disease: The Results of 89 Patients
07:30 AM - 12:00 PM Abstract 237 - Use of Rechargeable DBS Implantable Pulse Generators in Patients with Movement Disorders: Patient Satisfaction and Stimulation Parameters
07:30 AM - 12:00 PM Abstract 238 - Impact of Deep Brain Stimulation on Quality of Life in Parkinson's Disease: Long-Term Follow-Up
07:30 AM - 12:00 PM Abstract 239 - DJ-1 Based Peptide as a Novel Neuroprotective Strategy for Parkinson's Disease
07:30 AM - 12:00 PM Abstract 240 - Disease Modifying Strategy Based upon Iron Chelation in Parkinson's Disease: A Translational Study
07:30 AM - 12:00 PM Abstract 241 - Fox Trial Finder: An Innovative Web-Based Trial Matching Tool To Facilitate Clinical Trial Recruitment
07:30 AM - 12:00 PM Abstract 242 - Neurologist Care in PD Is Associated with Fewer PD Related Hospitalizations
07:30 AM - 12:00 PM Abstract 243 - Willingness of Parkinson Disease Patients To Participate in Research Using Internet-Based Technology
07:30 AM - 12:00 PM Abstract 244 - Patient Compliance with Parkinson's Disease Home Monitoring System
07:30 AM - 12:00 PM Abstract 245 - Institutional Outcomes in Patients Evaluated for Possible Normal Pressure Hydrocephalus: Which Factors Are Predictive of Positive Response to Ventriculoperitoneal Shunt Placement?
07:30 AM - 12:00 PM Abstract 246 - Immediate Versus Delayed Treatment of Psychogenic Movement Disorders with Short Term Psychodynamic Psychotherapy
07:30 AM - 12:00 PM Abstract 247 - Acute Vestibular Syndrome from Demyelinating Lesions
07:30 AM - 12:00 PM Abstract 248 - Left Entorhinal Cortex and Amygdala Hypermetabolism in Mal de Debarquement Syndrome
07:30 AM - 12:00 PM Abstract 249 - Small Posterior Fossa Strokes Causing Severe Vertigo - Clinical Signs and Anatomic Distribution of the "Lacunar" Acute Vestibular Syndrome
07:30 AM - 12:00 PM Abstract 250 - The Use of the Dix-Hallpike Test and the Canalith Repositioning Maneuver in Emergency Department Dizziness Presentations: A Population-Based Study
07:30 AM - 12:00 PM Abstract 251 - Vestibular Electrical Evoked Potential (VEEP) Findings in Normal Controls and in Patients with Vestibular Dysfunction
07:30 AM - 12:00 PM Abstract 252 - Impairment of the Vestibulo-Cerebellar Interaction in Friedreich's Ataxia
07:30 AM - 12:00 PM Abstract 253 - Gray-Matter Decrease in Chronic Somatoform Vertigo - A VBM Study
07:30 AM - 12:00 PM Abstract 255 - Hypertrophic Degeneration of the Inferior Olive Yields Erroneous Internal Estimates of Direction of Gravity
07:30 AM - 12:00 PM Abstract 256 - First Incidence Study of Meniere's Disease (MD) in South America
07:30 AM - 12:00 PM Abstract 257 - Convergence Insufficiency Responsive to Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
07:30 AM - 12:00 PM Abstract 258 - Saccadic Abnormalities in Familial Parkinson's Disease Associated with [alpha]-Synuclein (SNCA) Gene Mutation (PARK1)
07:30 AM - 12:00 PM Abstract 259 - Could Different Smooth Pursuit and Saccadic Abnormalities in Spinocerebellar Ataxia Type 3 (SCA3) Be Explained by a Single Deficient Mechanism?
07:30 AM - 12:00 PM Abstract 260 - Increasing Interval between Injections after Prolonged Onabotulinum Toxin Type A Use for Blepharospasm
07:30 AM - 12:00 PM Abstract 261 - Comparison of the Etiology and Prognosis of Fourth and Sixth Cranial Nerve Palsies
07:30 AM - 12:00 PM Abstract 262 - Memantine Improves Fixation Stability in Recessive Cerebellar Ataxia with Saccadic Intrusions
07:30 AM - 12:00 PM Abstract 263 - Fluctuating Ophthalmoplegia Presenting as a Treatable Manifestation of Myotonia Congenita
07:30 AM - 12:00 PM Abstract 264 - Ramsey Hunt Syndrome with Dysphagia with MRI Evidence of Brain Stem and Upper Cervical Cord Involvement
07:30 AM - 12:00 PM Abstract 265 - Recurrent Herpes Simplex Type-2 Meningoencephalitis as a Stroke Mimicker
07:30 AM - 12:00 PM Abstract 266 - The Relationship between Epstein-Barr Virus Infection and Multiple Sclerosis Detected by Indirect Immunofluorescence Assay
07:30 AM - 12:00 PM Abstract 267 - Case Report: HIV-2 Encephalitis in a Patient with Subacute Cognitive Decline
07:30 AM - 12:00 PM Abstract 268 - Varicella Zoster Virus Myelitis: A Report of Two Cases with Unusual Presentation
07:30 AM - 12:00 PM Abstract 269 - Foot Drop and Urinary Retention Following Disseminated Varicella Zoster Infection
07:30 AM - 12:00 PM Abstract 270 - Ganciclovir-Resistant Human Herpesvirus-6 Encephalitis in a Liver Transplant Patient: A Case Report
07:30 AM - 12:00 PM Abstract 271 - PML IRIS: A Difficult Diagnosis
07:30 AM - 12:00 PM Abstract 272 - Postmortem MRI in Progressive Multifocal Leukoencephalopathy
07:30 AM - 12:00 PM Abstract 273 - Progressive Multifocal Leukoencephalopathy in a Patient with Sarcoidosis
Faculty Disclosures
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Stephan A. Mayer, MD Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Alma R. Bicknese, MD Dr. Bicknese has nothing to disclose.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
S. A. Josephson, MD, FAAN Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Neeraj Badjatia, MD The institution of Dr. Badjatia has received research support from NIH/DOD.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Aikaterini Kompoliti, MD, FAAN Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Scott S. Zamvil, MD, PhD, FAAN Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Jose Carlos Alvarez Cermeno, MD No disclosure on file
Fred Rincon, MD Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit LLC.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical 好色先生 Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with 好色先生 that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Aatif M. Husain, MD Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Methodist Hospital. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedIQ. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceutical. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. The institution of Dr. Husain has received research support from PranaQ. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with American Clinical Neurophysiology Society. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Moses Rodriguez, MD, FAAN Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
No disclosure on file
Jan Claassen, MD, PhD Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Kiwon Lee, MD No disclosure on file
David E. Newman-Toker, MD, PhD, FAAN The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
W. T. Longstreth, Jr., MD, FAAN The institution of Dr. Longstreth has received research support from NIH.
Marcel Hungs, MD, PhD, FAAN No disclosure on file
Javier Olaskoaga Urtaza, MD No disclosure on file
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Lynn Wiryasaputra No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
Srikanth Damodaram, MD No disclosure on file
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Mariko Kita, MD No disclosure on file
Nitin J. Karandikar, MD, PhD No disclosure on file
Frank Dahlke, MD, PhD Dr. Dahlke has received personal compensation for serving as an employee of Novartis.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Russell Tracy No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Yuehjien Gu, MD No disclosure on file
Malcolm H. Gottesman, MD, FAAN No disclosure on file
Olga Ciccarelli, MD, PhD, FRCP Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundebeck. Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Barry M. Czeisler, MD, MS, MHPE, FAAN Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroStat Consulting LLC. Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace. Dr. Czeisler has received publishing royalties from a publication relating to health care.
Aashit K. Shah, MD, FAAN Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Danielle Weinberg No disclosure on file
John Pula, MD, FAAN Dr. Pula has nothing to disclose.
Edythe Boitnott No disclosure on file
Lucas Restrepo, MD, PhD Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Beomseok Jeon, MD Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Philip R. Kennedy, MD, PhD No disclosure on file
Kathrin Gerbershagen, MD No disclosure on file
Shuhei Nishiyama, MD No disclosure on file
Peachie N. Moore, BA No disclosure on file
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Sharmilee Gnanapavan, MB Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR.
Umer Akbar, MD Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Masashi Aoki, MD, PhD Masashi Aoki, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tanabe Mitsubishi.
Caroline Pot Kreis, MD No disclosure on file
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Barbara Hager, MD No disclosure on file
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Maria Diaz Lorente, MD No disclosure on file
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Stephan Schmidt, MD No disclosure on file
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Lauren B. Krupp, MD, FAAN Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Catherine Cho, MD Dr. Cho has nothing to disclose.
Michael Lang, MD No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Michael Quach, MD No disclosure on file
Patricia E. Penovich, MD, FAAN Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
Marcelo C. Kremenchutzky, MD, FAAN No disclosure on file
Dagny N. Holle, MD Dr. Holle has nothing to disclose.
Terri J. Kiernan, NP No disclosure on file
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Elizabeth A. Sekul, MD No disclosure on file
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Kaavya Narasimhalu, MD, PhD No disclosure on file
Michael Hecker, PhD No disclosure on file
Nagaendran Kandiah, MD No disclosure on file
Andrew Gomez-Vargas, MD No disclosure on file
Thomas Dehmel No disclosure on file
Vladimir S. Kostic, MD, PhD Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of 好色先生, Science and Technological Development of Serbia.
Martin Marziniak, PhD No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Mark A. Ross, MD, FAAN No disclosure on file
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Deidre J. Devier, PhD No disclosure on file
Sara Loud Ms. Loud has received personal compensation for serving as an employee of Accelerated Cure Project, Inc. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Ms. Loud has received research support from National MS Society.
Katja Thomas, MD No disclosure on file
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Chethan P. Venkatasubba Rao, MD Dr. Venkatasubba Rao has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Maestro Inc.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Tzu-Ching Wu, MD Dr. Wu has nothing to disclose.
Christopher M. Everett, MBBS, PhD No disclosure on file
Tatsuro Misu No disclosure on file
Mark Obermann, MD, FAAN No disclosure on file
Jeffrey S. Kutcher, MD, FAAN Dr. Kutcher has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Dan J. Capampangan, MD, FAAN No disclosure on file
Rodney D. Bell, MD Dr. Bell has received publishing royalties from a publication relating to health care.
Michael M. Moussouttas, MD No disclosure on file
Victor W. Mark, MD Dr. Mark has nothing to disclose.
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Toshiaki Takahashi No disclosure on file
Paul M. Thompson, PhD No disclosure on file
Brian Scott, MD Dr. Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend Biotech.
Emily Camp No disclosure on file
Hollie K. Schmidt Ms. Schmidt has received personal compensation for serving as an employee of Accelerated Cure Project for MS.
Archana Hinduja, MD Dr. Hinduja has nothing to disclose.
Richard W. Price, MD, FAAN No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Fernando J. Caceres, MD No disclosure on file
Clement Francois No disclosure on file
Emily L. Evans, MD Dr. Evans has received personal compensation for serving as an employee of EMD Serono. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis.
Salah G. Keyrouz, MD No disclosure on file
Timothy J. Ingall, MBBS, PhD Dr. Ingall has nothing to disclose.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Michel P. Rathbone, MD, PhD No disclosure on file
Kilidirea Constantinos, MD No disclosure on file
Teri Schreiner, MD, MPH, FAAN The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Brigitte Wildemann, MD The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Vivek Misra, MD Dr. Misra has nothing to disclose.
Nicholas E. Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. Dr. Johnson has stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Wei-Qiao Liu, MD No disclosure on file
Gianna Carla Riccitelli No disclosure on file
Varina Boerwinkle, MD Dr. Boerwinkle has nothing to disclose.
Sergio Baranzini Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Salah Foundation. The institution of Sergio Baranzini has received research support from NIH. The institution of Sergio Baranzini has received research support from NSF. Sergio Baranzini has received intellectual property interests from a discovery or technology relating to health care. Sergio Baranzini has a non-compensated relationship as a co-funder with Mate Bioservices that is relevant to AAN interests or activities.
Tatiana Witjas No disclosure on file
Antonella Palla, MD No disclosure on file
Mark Dolev Dolgopiat, MD No disclosure on file
Jacqueline Urtecho, MD Dr. Urtecho has nothing to disclose.
Andreas V. Alexopoulos, MD, MPH Dr. Alexopoulos has nothing to disclose.
Lindsey B. DeLott, MD, FAAN Dr. DeLott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Dr. DeLott has received research support from National Institutes of Health. The institution of Dr. DeLott has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. DeLott has received research support from Research to Prevent Blindness. Dr. DeLott has received intellectual property interests from a discovery or technology relating to health care.
Sarah Kranick, MD Dr. Kranick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Verana Health.
Scott Mintzer, MD No disclosure on file
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Claude Nguyen, MD Dr. Nguyen has nothing to disclose.
Guillermo Videla, MD No disclosure on file
Manolo E. Beelke, MD, PhD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Yuko Palesch No disclosure on file
Haralambos Alexopoulos No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Anna Jurewicz, MD No disclosure on file
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Anna M. Szekely, MD No disclosure on file
Santosh B. Murthy, MD Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Chilvana V. Patel, MBBS, FAAN Dr. Patel has nothing to disclose.
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Tobias Loddenkemper, MD, FAAN No disclosure on file
Kaviraja Udupa, MD, PhD No disclosure on file
David Leppert, MD Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Andrew D. Barreto, MD No disclosure on file
Swaroop Pawar, MD Dr. Pawar has nothing to disclose.
Bettina Balint, MD Dr. Balint has received publishing royalties from a publication relating to health care.
Axel Methner, MD No disclosure on file
Margaret E. Burnett, MD Dr. Burnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prism. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Burnett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Burnett has received research support from Genentech.
David Schiff, MD, FAAN Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
Miriam Mattoscio, MD, PhD, FAAN Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK SERONO.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Andrew M. Naidech, MD, FAAN Dr. Naidech has received publishing royalties from a publication relating to health care.
Peter Wipfler Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
David Magalashvili, MD No disclosure on file
Paola Valsasina Paola Valsasina has nothing to disclose.
Lorenz Lehr, PhD No disclosure on file
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Yoon-Hee Cha, MD, FAAN The institution of Dr. Cha has received research support from Mal de Debarquement Balance Disorders Foundation. Dr. Cha has received research support from University of Minnesota. Dr. Cha has received research support from MNDrive.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Paolo A. Muraro, MD, PhD No disclosure on file
Michael Gurevich No disclosure on file
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Karen Odrzywolski, MD Dr. Odrzywolski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Empire State Medical, Scientific and 好色先生al Foundation.
Juergen Haas Juergen Haas has nothing to disclose.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
Edward W. Brydon, PhD No disclosure on file
Matthew Maas, MD, FAAN The institution of Dr. Maas has received research support from National Institutes of Health.
Analia Calle Analia Calle has nothing to disclose.
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Marijean Buhse Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Jeffrey M. Gelfand, MD, MS, FAAN Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Nirit Lev, MD No disclosure on file
Eldad Melamed, MD No disclosure on file
Alexander A. Tarnutzer, MD No disclosure on file
George A. Lopez, MD, PhD No disclosure on file
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Geoffrey K. Aguirre, MD, PhD Dr. Aguirre has received stock or an ownership interest from Nia therapeutics. The institution of Dr. Aguirre has received research support from Lion's Foundation. The institution of Dr. Aguirre has received research support from National Institutes of Health. The institution of Dr. Aguirre has received research support from Johnson and Johnson. The institution of Dr. Aguirre has received research support from Department of Defense.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Yazan Alderazi, MD, MB BCh BAO No disclosure on file
Glenn T. Stebbins, PhD Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Andrea Vincent Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
William McBride, MD Dr. McBride has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Elizabeth Waterhouse, MD, FAAN Dr. Waterhouse has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Waterhouse has received research support from Xenon.
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Michael Gillette No disclosure on file
Evanthia Bernitsas, MD, FAAN Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Silke A. Cresswell, MD No disclosure on file
Allison Wright Willis, MD Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Francesca Ruffini, PhD No disclosure on file
Lloyd H. Kasper, MD No disclosure on file
Debabrata Ghosh, MD No disclosure on file
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Avindra Nath, MD, MBBS, FAAN The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Mary Guanci No disclosure on file
Kevin M. Flanigan, MD, FAAN Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity.
Laura Airas, MD, PhD Dr. Airas has nothing to disclose.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Richard F. Lewis, MD No disclosure on file
Deepak S. Nair, MD Dr. Nair has nothing to disclose.
Bryan A. Bernard, PhD Dr. Bernard has nothing to disclose.
Jonathan Howard, MD Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Thomas Engberg No disclosure on file
Judith Haas, MD No disclosure on file
Kelly Baldwin, MD Dr. Baldwin has nothing to disclose.
Andre Kumar No disclosure on file
Erwin Chiquete, MD, PhD No disclosure on file
Matthew Vibbert, MD Dr. Vibbert has nothing to disclose.
Anna Jalkanen, MD No disclosure on file
Jutta Gaertner, MD Dr. Gaertner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gaertner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Gaertner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gaertner has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Biogen.
Keith R. Edwards, MD, FAAN No disclosure on file
Marie Atkinson, MD No disclosure on file
Dale J. Lange, MD, FAAN No disclosure on file
David Y. Hwang, MD, FAAN The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
Michael J. Turner, PhD No disclosure on file
Elaine Wyllie, MD Dr. Wyllie has received publishing royalties from a publication relating to health care.
Daniel Mielcarz No disclosure on file
Ulf Schulze Topphoff Ulf Schulze Topphoff has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Owen T. Carmichael, PhD No disclosure on file
Johann Sellner, MD, FAAN Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Alexander Fong, MD No disclosure on file
George Dale George Dale has nothing to disclose.
Mario Riverol, MD No disclosure on file
A. H. Hewazy, FRCP (G), FRCP(L), F No disclosure on file
Olimpia Carbunar, MD The institution of Dr. Carbunar has received research support from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The institution of Dr. Carbunar has received research support from ARGENX/PPD.
Nicolas Molnarfi No disclosure on file
H. M. Gach, PhD MS No disclosure on file
Kavita M. Grover, MD, FAAN Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Hashem Shaltoni, MD Dr. Shaltoni has nothing to disclose.
Jacqueline Channon-Smith No disclosure on file
Edward J. Atkins, MD No disclosure on file
Borna Bonakdarpour, MD, FAAN Dr. Bonakdarpour has nothing to disclose.
Kirk A. Frey, MD, PhD No disclosure on file
Stanton B. Elias, MD No disclosure on file
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Ashley Boller No disclosure on file
Suzanne Strickland, MD No disclosure on file
Jimmy Holder, MD Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Anita L. Belman, MD, FAAN No disclosure on file
Navid Seraji-Bozorgzad, MD No disclosure on file
Jack Jallo, MD No disclosure on file
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Iris Katharina Penner, PhD The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Volker Limmroth, MD, PhD No disclosure on file
Kirk Kleinfeld, MD No disclosure on file
James T. Eckner, MD An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a 好色先生al Content Contributor with Move United.
Alexander Ramos, MD No disclosure on file
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Nicolas Collongues, MD Nicolas Collongues, MD has nothing to disclose.
Lutz Harms No disclosure on file
Ariel L. Miller, MD, PhD Dr. Miller has nothing to disclose.
Yazhong Tao No disclosure on file
Bruce Roberts, PhD No disclosure on file
Robert C. Sergott, MD Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Halina Wygladalska-Jernas, MD No disclosure on file
Christian A. Robles, MD Dr. Robles has nothing to disclose.
Amy Y. Yu, MD No disclosure on file
Luc Defebvre No disclosure on file
Aaron Vinik No disclosure on file
Christoph J. Schankin, MD The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
Caterina Rosano, MD, MPH No disclosure on file
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
David Devos The institution of Mr. Devos has received research support from Alterity.
Eugenia Ho, MD Dr. Ho has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Armenia Neurology Conference. Dr. Ho has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sanders Warren and Russell LLP.
Gary Steinberg, MD, PhD Dr. Steinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SanBio. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zeiss. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgical Theater. Dr. Steinberg has received research support from National Institutes of Health. Dr. Steinberg has received research support from California Institute of Regenerative Medicine. Dr. Steinberg has received intellectual property interests from a discovery or technology relating to health care.
Michael D. Hill, MD Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Mario Zappia, MD No disclosure on file
Lukasz Jernas, PhD No disclosure on file
Marie-Laure Santiago-Raber, PhD No disclosure on file
Saad Abu Saleh No disclosure on file
Jocelyn Y. Cheng, MD, FAAN Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
Elzbieta Tokarz-Kupczyk, MD No disclosure on file
Frederic Blanc No disclosure on file
Douglas Bigwood No disclosure on file
Pierre Payoux No disclosure on file
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Francois Chollet, MD No disclosure on file
Francois D. Jacob, MD No disclosure on file
Selim R. Benbadis, MD, FAAN Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
Lisa Silbert, MD, FAAN The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Robert E. Hoesch, MD, PhD No disclosure on file
Brant Oliver Brant Oliver has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for @ Point of Care. The institution of Brant Oliver has received research support from Biogen.
Brigitte Paap No disclosure on file
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Brian Crum, MD Dr. Crum has nothing to disclose.
Caroline Moreau, MD No disclosure on file
Leslie J. Dorfman, MD No disclosure on file
Michael A. Panzara, MD, MPH Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.
John Shoffner IV, MD No disclosure on file
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Slawomir Michalak, PhD No disclosure on file
Katia Noyes No disclosure on file
Jaya Trivedi, MD, FAAN The institution of Dr. Trivedi has received research support from Avidity.
Paola Tortorella No disclosure on file
Andrea Almeida, MD Dr. Almeida has nothing to disclose.
Arnaud Lacour No disclosure on file
Michel Thiebaut De Schotten No disclosure on file
David N. Herrmann, MD, FAAN Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
John B. Williamson No disclosure on file
Klaus-Peter Wandinger, MD No disclosure on file
Rina Aharoni, PhD No disclosure on file
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Hebun Erdur, MD No disclosure on file
Ashish A. Vyas, MD No disclosure on file
Gene L. Bowman, ND No disclosure on file
Nancy Monson Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care.
Megan R. Rahmlow, MD No disclosure on file
Sarah Ryan No disclosure on file
Volker A. Knappertz, MD Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
David V. Lardizabal, MD, FAAN Dr. Lardizabal has nothing to disclose.
Edward Croze, PhD No disclosure on file
Alaa Abu Saleh No disclosure on file
Annalisa Barracchini No disclosure on file
Jeanne S. Teitelbaum, MD No disclosure on file
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Xin Zhang No disclosure on file
Lynne Shinto, ND No disclosure on file
Judith A. Hinchey, MD No disclosure on file
Daniel Weber, DO Dr. Weber has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Svjetlana Miocinovic, MD, PhD Dr. Miocinovic has nothing to disclose.
Kogul Arumaithurai, MD Dr. Arumaithurai has nothing to disclose.
Denise Cheng, RN, BSN No disclosure on file
Adolfo Lopez De Munain No disclosure on file
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
Nicolas A. Bianchi, MD Dr. Bianchi has received personal compensation in the range of $0-$499 for serving as a Consultant for Innovation Hub Enterprises, LLC. The institution of Dr. Bianchi has received research support from Emory Medical Care Foundation.
Antonios Bayas No disclosure on file
Samuel J. Potolicchio, Jr., MD No disclosure on file
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Aparna Shetty No disclosure on file
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Bashir S. Shihabuddin, MD No disclosure on file
Francesca Rosini, MD No disclosure on file
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Volker Brinkmann, PhD No disclosure on file
Radi S. Shahien, MD Dr. Shahien has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Marco Rovaris No disclosure on file
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Fred Luhder No disclosure on file
Berit Rosche No disclosure on file
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Shiv Saidha, MD Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Seema K. Tiwari-Woodruff, PhD No disclosure on file
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Jitesh Rana, MD, MBBS No disclosure on file
David L. Gordon, MD, FAHA, FANA, FAAN Dr. Gordon has nothing to disclose.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Robert Malka, MD No disclosure on file
Andrew R. Pachner, MD No disclosure on file
Richard M. Hanson, MD No disclosure on file
Roopali Gandhi, PhD No disclosure on file
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Roger M. Kurlan, MD, FAAN No disclosure on file
nobl barazangi, MD, PhD Dr. Barazangi has nothing to disclose.
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Hitha Amin, MD, MBBS No disclosure on file
James T. Becker, PhD No disclosure on file
John W. Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Omar Khwaja, MD No disclosure on file
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Ioanna Chatzi No disclosure on file
Xiaoyan Jiang, PhD No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Robert Staudinger, MD, FAAN Dr. Staudinger has nothing to disclose.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Jean-Pascal Lefaucheur No disclosure on file
Alberto R. Figueroa, MD No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Alain Destee, MD, PhD No disclosure on file
David S. Saperstein, MD No disclosure on file
Anitha Rao, MD An immediate family member of Dr. Rao has received personal compensation for serving as an employee of Abbvie. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurovision. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Virtusense. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. An immediate family member of Dr. Rao has stock in Abbvie. Dr. Rao has a non-compensated relationship as a Executive Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Deepti Chrusciel, MD Dr. Chrusciel has nothing to disclose.
Hiroko H. Dodge, PhD No disclosure on file
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Eric M. Eastman, PhD No disclosure on file
Dhruvil J. Pandya, MD No disclosure on file
Jack C. Rose, MD No disclosure on file
Armando S. Miciano, MD, FAAPMR No disclosure on file
David Shprecher, DO, FAAN Dr. Shprecher has received personal compensation for serving as an employee of Banner Health. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanders+Parks. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medplace. The institution of Dr. Shprecher has received research support from MJFF. The institution of Dr. Shprecher has received research support from Cognition Therapeutics. The institution of Dr. Shprecher has received research support from Biogen. The institution of Dr. Shprecher has received research support from Neuraly. The institution of Dr. Shprecher has received research support from Jazz Pharmaceuticals. The institution of Dr. Shprecher has received research support from Sanofi Aventis. The institution of Dr. Shprecher has received research support from Annovis. The institution of Dr. Shprecher has received research support from Neurocrine. The institution of Dr. Shprecher has received research support from Teva. The institution of Dr. Shprecher has received research support from Nuvelution. The institution of Dr. Shprecher has received research support from EIP Pharma. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson's and MDS. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Parkinson's Movement Disorder Alliance.
Anke Stroet, MD No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Maria E. Gonzalez Toledo, MD No disclosure on file
Marco Catani, MD No disclosure on file
Stanley Krolczyk, MD No disclosure on file
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Maider Mu[ntilde]oz-Culla No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Saugat Dey, MD No disclosure on file
Shawn Smyth, MD Dr. Smyth has nothing to disclose.
Jorge C. Kattah, MD, FAAN Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Steffen Naegel, MD No disclosure on file
Parul Chaudhary No disclosure on file
Patricia A. Nelson, PhD No disclosure on file
Galeno Rojas, MD No disclosure on file
Jose I. Suarez, MD, FAAN Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.
Michel Varrin-Doyer No disclosure on file
Arunodaya R. Gujjar, MBBS, DM, FRCP Dr. Gujjar has nothing to disclose.
Sharon Ash No disclosure on file
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Jakob Bauer No disclosure on file
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Lisa Burkholder No disclosure on file
Steven Broglio, PhD Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MCW. Dr. Broglio has received personal compensation in the range of $0-$499 for serving as a Consultant for U Calgary. Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Montgomery McCracken Walker & Rhoads LLP. The institution of Dr. Broglio has received research support from DoD. The institution of Dr. Broglio has received research support from NCAA.
Trinh Pham No disclosure on file
Maria I. Aguilar, MD Dr. Aguilar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech.
Tamara Castillo-Trivino, MD, MAS, FAAN Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Klemens Ruprecht, MD Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Anne Foundas, MD, FAAN No disclosure on file
Tae Jung Kim, MD No disclosure on file
Frauke Zipp, MD Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Nicholas Perros No disclosure on file
Pamela Dean No disclosure on file
Vivek Rai, MD Dr. Rai has nothing to disclose.
Satish Agadi, MD Dr. Agadi has nothing to disclose.
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Ichiro Nakashima, MD, PhD Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Eric Bershad, MD Dr. Bershad has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various.
Nir Dotan No disclosure on file
Achim Gass, MD Dr. Gass has nothing to disclose.
Federico Di Guglielmo No disclosure on file
Siddharama Pawate, MD The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Abdullah Al-Asmi, MD No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Sashank Prasad, MD Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Lana Zhovtis Ryerson, MD, FAAN Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Oren S. Cohen, MD No disclosure on file
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Jingya Zhang, PhD No disclosure on file
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Clara De Andres, MD No disclosure on file
Robert W. Baloh, MD, FAAN No disclosure on file
Anthony Reder, MD Dr. Reder has nothing to disclose.
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Daniel Kremens, MD, JD, FAAN Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
John Powers No disclosure on file
Ari Waisman No disclosure on file
Wayne T. Cornblath, MD, FAAN Dr. Cornblath has nothing to disclose.
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Luisa M. Villar Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Cyrus A. Raji No disclosure on file
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Nurkia A. Mihu, MD No disclosure on file
Edgardo G. Reich, Sr., MD No disclosure on file
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Reid D. Taylor, MD Dr. Taylor has nothing to disclose.
Gareth R. John No disclosure on file
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Franck Durif, MD, PhD No disclosure on file
Alexander Schneider, MD No disclosure on file
Steven Moore, PhD No disclosure on file
Vanja C. Douglas, MD, FAAN Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Tracey A. Knaus, PhD No disclosure on file
Karin Rehberg-Weber No disclosure on file
Elaine C. Wirrell, MD, FAAN Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Michele Puel, MD No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
E. Ray Dorsey, MD, MBA Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP 好色先生, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Sean Lanigar, MD Dr. Lanigar has nothing to disclose.
Katherine C. Nickels, MD, FAAN The institution of Dr. Nickels has received research support from Zogenix. The institution of Dr. Nickels has received research support from Marinus. The institution of Dr. Nickels has received research support from Bio-Pharm Solutions. The institution of Dr. Nickels has received research support from Pediatric Epilepsy Research Foundation. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Faculty with J. Kiffin Penry 好色先生al Programs.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Thomas J. Montine, MD, PhD Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care.
R. John Leigh, MD No disclosure on file
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Silva Markovic-Plese, MD, FAAN Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Maria Luisa Martinez Gines, MD Dr. Martinez Gines has nothing to disclose.
Ibon Garitaonandia No disclosure on file
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Pramod R. Gupta, MD No disclosure on file
Maria C. Ysrraelit No disclosure on file
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Dustin A. Heldman, PhD Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Jerry Prince No disclosure on file
Dwain Tolbert, PhD No disclosure on file
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Jeffrey J. Raizer, MD No disclosure on file
Kevin M. Biglan, MD Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Collin M. Spencer No disclosure on file
Marie Fleury No disclosure on file
Lauren Mylacraine No disclosure on file
Man Mohan Mehndiratta, MD, MBBS, FAAN Dr. Mehndiratta has nothing to disclose.
Scott Patten, PhD Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care.
David B. Burtis, DO No disclosure on file
Craig S. Moore, PhD Dr. Moore has nothing to disclose.
David C. Tong, MD, FAHA No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
Keith Hyland, PhD No disclosure on file
Joseph Giuffrida, PhD No disclosure on file
Susan E. Goelz, PhD No disclosure on file
Silvia Messina No disclosure on file
Pascal Laforet No disclosure on file
David Turkel-Parrella, MD No disclosure on file
Pradeep Bista No disclosure on file
Nancy Maalouf, MD No disclosure on file
Maira Gironi No disclosure on file
Andrew H. Chan, MD No disclosure on file
Clemence Simonin, MD No disclosure on file
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Mauricio F. Farez, MD Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Marianne Giroux No disclosure on file
Amie L. Hiller, MD The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Alcy Torres, MD Dr. Torres has nothing to disclose.
Kevin A. Kerber, MD Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. The institution of Dr. Kerber has received research support from National Institutes of Health. The institution of Dr. Kerber has received research support from Genentech, Inc . Dr. Kerber has received publishing royalties from a publication relating to health care.
Jefferson Miley, MD No disclosure on file
Thomas A. Ala, MD No disclosure on file
Daniel Antoniello, MD Dr. Antoniello has nothing to disclose.
Sonya G. Wang, MD Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics.
Enzo Grossi No disclosure on file
Deborah A. Lee, MD, PhD No disclosure on file
Stephen M. Strittmatter, MD, PhD Dr. Strittmatter has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allyx. Dr. Strittmatter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proteowise. Dr. Strittmatter has stock in Allyx. Dr. Strittmatter has stock in Proteowise. Dr. Strittmatter has stock in ReNetX. The institution of Dr. Strittmatter has received research support from Proteowise. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care.
Norbert Goebels, MD Dr. Goebels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Goebels has received research support from Sanofi-Genzyme.
Christine Tranchant, MD No disclosure on file
David J. Szmulewicz, MD No disclosure on file
Deepa Kannaditharayil, MD No disclosure on file
Mark A. Paine, MD, MBBS, FRACP No disclosure on file
Ramin Zand, MD Dr. Zand has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for StrokeExperts. The institution of Dr. Zand has received research support from NIH. The institution of Dr. Zand has received research support from PCORI.
Carissa Pineda, MD Dr. Pineda has nothing to disclose.
John A. Morren, MD, FAAN Dr. Morren has received publishing royalties from a publication relating to health care.
Prakash R. Paliwal, MD No disclosure on file
Ulf Ziemann, MD No disclosure on file
Burk Jubelt, MD No disclosure on file
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Sohail M. Malek, MD No disclosure on file
Aftab Ahmad, MD Dr. Ahmad has nothing to disclose.
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Danna L. Jennings, MD Dr. Jennings has received personal compensation for serving as an employee of Denali Therapeutics . Dr. Jennings has received stock or an ownership interest from Denali Therapeutics.
Brenda L. Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Brian Callaghan, MD, MS, FAAN Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from 好色先生. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Patrick K. Kwan, MD, PhD No disclosure on file
Efrain D. Salgado, MD Dr. Salgado has nothing to disclose.
Ajit Dhaunchak, PhD No disclosure on file
Rebecca Folkerth, MD Rebecca Folkerth, MD has nothing to disclose.
Claire C. Meunier No disclosure on file
Joerg R. Kraus, MD No disclosure on file
Marko Chatzopoulos, PhD No disclosure on file
William J. Meurer, MD Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Berry Consultants. The institution of Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meurer Consulting. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Emergency Medicine. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Trials Journal . Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Academic Emergency Medicine Journal. Dr. Meurer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Meurer Consulting. The institution of Dr. Meurer has received research support from NIH and AHRQ. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of Grants and FDA submissions with NIH and FDA. Dr. Meurer has a non-compensated relationship as a Member of Board of Directors with Society for Clinical Trials that is relevant to AAN interests or activities.
Kiren Kresa-Reahl, MD Dr. Kresa-Reahl has received personal compensation for serving as an employee of Atara Biotherapeutics Inc.. Dr. Kresa-Reahl has received stock or an ownership interest from Atara Biotherapeutics Inc.
Jean P. Azulay, MD Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Andrew C. Bragdon, MD No disclosure on file
Joanna S. Blackburn, MD Dr. Blackburn has nothing to disclose.
Alexandre Eusebio, MD No disclosure on file
Olga Waln, MD Dr. Waln has nothing to disclose.
Joel S. Perlmutter, MD, FAAN Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
Joon Y. Kang, MD Dr. Kang has nothing to disclose.
Meheroz H. Rabadi, MD, FAAN Dr. Rabadi has nothing to disclose.
Joohi Jimenez Shahed, MD, FAAN Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with 好色先生. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
Jaskaran Rakkar No disclosure on file
Devin L. Brown, MD, FAAN The institution of Dr. Brown has received research support from NIH.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Daniel Roque, MD No disclosure on file
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
David Irwin, MD The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Sara Z. Bahar, MD No disclosure on file
Wei Ping Kay Ng, MD Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
Shyama Satyan, MBBS No disclosure on file
Murray S. Flaster, MD, PhD No disclosure on file
A. Mark Fendrick No disclosure on file
Brad A. Racette, MD, FAAN Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Andres M. Villa, MD Dr. Villa has nothing to disclose.
A. M. Barrett, MD, FAAN The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Jane Boggs, MD The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Luciana Melamud No disclosure on file
Christa Watson No disclosure on file
Elisabeth G. Kramer, MD No disclosure on file
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Pavan Bhargava, MD, FAAN The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Ben Wakerley, MD No disclosure on file
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Joshua P. Klein, MD, PhD, FANA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Hania Kebir, PhD Ms. Kebir has received research support from Fonds de Recherche du Québec-Santé. Ms. Kebir has received intellectual property interests from a discovery or technology relating to health care.
De-Hyung Lee, MD No disclosure on file
Russell A. Kern, PhD No disclosure on file
Vijay Sharma No disclosure on file
Tariq B. Alfahad, MD No disclosure on file
Sungpil Han No disclosure on file
Priyanka P. Shah-Basak, PhD The institution of Dr. Shah-Basak has received research support from NIH NIDCD. The institution of Dr. Shah-Basak has received research support from NIH NIDCD.
Jennifer A. Vermilion, MD The institution of Dr. Vermilion has received research support from Centers for Disease Control. The institution of Dr. Vermilion has received research support from Emalex Biosciences. The institution of Dr. Vermilion has received research support from Biomarin. The institution of Dr. Vermilion has received research support from Neurogene, Inc. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Tourette Association of America. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Centers for Disease Control and Prevention and American Academy of Pediatrics.
Leah Gaedeke, MSN, FNP-BC No disclosure on file
Leslie M. Shaw, PhD Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Shaw has received research support from NIA. The institution of Dr. Shaw has received research support from MJ Fox foundation for Parkinsons Research.
Facundo Manes No disclosure on file
David Race No disclosure on file
Jason Cuomo No disclosure on file
Helene Masson, MD No disclosure on file
Erdem Tuzun Erdem Tuzun has nothing to disclose.
Jose Biller, MD, FACP, FAHA, FAAN Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Loh Pei Kee, MD No disclosure on file
Kendra R. Cagniart, MD Dr. Cagniart has nothing to disclose.
Noam Harel, MD, PhD Dr. Harel has received personal compensation for serving as an employee of James J. Peters VA Medical Center. Dr. Harel has received personal compensation for serving as an employee of Icahn School of Medicine at Mount Sinai. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RubiconMD. Dr. Harel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dalton & Finegold, LLP. The institution of Dr. Harel has received research support from NIH. The institution of Dr. Harel has received research support from Craig H. Neilsen Foundation. The institution of Dr. Harel has received research support from New York State Department of Health. The institution of Dr. Harel has received research support from VA Rehabilitation Research and Development. Dr. Harel has a non-compensated relationship as a Neurology Editorial Board Member with AAN that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Member, Board of Directors with American Society of Neurorehabilitation that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Chair, AAN Spine Section with AAN that is relevant to AAN interests or activities.
Burkhard Becher, PhD No disclosure on file
Fatta B. Nahab, MD, FAAN Dr. Nahab has received personal compensation for serving as an employee of Neuron23. Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ActualSignal. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Attune Neurosciences, Inc.. Dr. Nahab has stock in Biogen. Dr. Nahab has received personal compensation in the range of $500-$4,999 for serving as a DSMB Member with NIH.
Stanley L. Cohan, MD, PhD, FAAN Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Philippe Truffinet, MD Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Steven E. Arnold, MD Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Michael G. Halmagyi, MD Dr. Halmagyi has nothing to disclose.
Lewis B. Morgenstern, MD, FAAN No disclosure on file
Vikram Jadhav, MD No disclosure on file
Jennifer Takesaka, MD Dr. Takesaka has nothing to disclose.
Neil Rosenberg, MD Dr. Rosenberg has nothing to disclose.
Clemens Warnke The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Bibiana Bielekova, MD, FAAN Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Glenn D. Graham, MD, PhD, FAAN Dr. Graham has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with MER (non-profit CME provider). Dr. Graham has received personal compensation in the range of $500,000-$999,999 for serving as a Employee with Department of Veterans Affairs. An immediate family member of Dr. Graham has received personal compensation in the range of $100,000-$499,999 for serving as a Exployee with Department of Veterans Affairs.
Christine B. Hunter, RN, BSN No disclosure on file
Chetan Malpe, MD No disclosure on file
Joel J. Oger, MD, FRCPC, FAAN No disclosure on file
Jennifer Lyons, MD Dr. Lyons has received personal compensation for serving as an employee of Biogen. Dr. Lyons has received stock or an ownership interest from Biogen.
Tomo Tarui, MD Dr. Tarui has nothing to disclose.
Paola Fortis No disclosure on file
Diane Sierens, MD No disclosure on file
Virginia Lee, PhD Virginia Lee, PhD has nothing to disclose.
Domingo O. Garcea, MD No disclosure on file
Richard Phillips, MD Dr. Phillips has nothing to disclose.
Pravin George, DO Dr. George has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Fabienne Ory Fabienne Ory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Fabienne Ory has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Fabienne Ory has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for aguettant. Fabienne Ory has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for abbvie. The institution of Fabienne Ory has received research support from fondation santé recherche.
Mansour Afshani, MD Dr. Afshani has nothing to disclose.
Alexandre Prat, MD The institution of Dr. Prat has received research support from CIHR and MSSC.
Peii Chen No disclosure on file
Steve Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Michael Phipps, MD, MHS, FAAN Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
Joao A. Gomes, MD Dr. Gomes has nothing to disclose.
Fadi B. Nahab, MD Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Alfredo Damasceno, MD No disclosure on file
Jonathan W. Mink, MD, PhD, FAAN The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Reva C. Wilheim No disclosure on file
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Sandra Vanotti, MD No disclosure on file
Samish Dhungana, MD No disclosure on file
Carlos Otavio Brandao, MD, PhD No disclosure on file
Mohan Kottapally, MD Dr. Kottapally has nothing to disclose.
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Leonard L. Yeo, MBBS The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Tony Sehr No disclosure on file
Bingbing Li Bingbing Li has received personal compensation for serving as an employee of Novartis.
Undine Hainke No disclosure on file
Fabio O. Danisi, MD Dr. Danisi has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Marilyn Matthew No disclosure on file
Barry G. Arnason, MD No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Joseph Herbert, MD No disclosure on file
Jorge O. Norscini, MD No disclosure on file
Maria Del Mar Saniger-Alba, MD No disclosure on file
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Catherine Ham, MD No disclosure on file
Shalaka D. Indulkar, MD No disclosure on file
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Linda P. Lowes, PT PhD The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Kiel Telesford No disclosure on file
Muhammad H. Jaffer, MD Dr. Jaffer has nothing to disclose.
Kaj Blennow Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Latt Latt Aung, MD No disclosure on file
Mark A. Jensen, PhD No disclosure on file
Agata Walczak, MD No disclosure on file
Maria Laura Stromillo, PhD Maria Laura Stromillo, PhD has nothing to disclose.
Maria D. Benedetti, MD No disclosure on file
Maciej Jurynczyk, MD No disclosure on file
Cindy Benton, MSN, FNP-C No disclosure on file
Tomas Olsson, MD, PhD Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Olsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Olsson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Prof. Olsson has received research support from Biogen. The institution of Prof. Olsson has received research support from Novartis. The institution of Prof. Olsson has received research support from Sanofi. The institution of Prof. Olsson has received research support from Merck.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Sean Hwang, MD Dr. Hwang has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Jeffrey Craig, MD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Salsabil Haque No disclosure on file
Yael Stern No disclosure on file
Philippe P. Derost No disclosure on file
Sakhina Begum-Haque, PhD No disclosure on file
Peter Huppke No disclosure on file
Carmel Armon, MD, FAAN Dr. Armon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inbal - Israeli Government Insurance Company. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurological Sciences. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Individual attorney offices. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Civil Courts as a court-appointed expert. Dr. Armon has received publishing royalties from a publication relating to health care.
Sharon Hassin-Baer, MD Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Elizabeth A. Freeman No disclosure on file
Andrea Falini No disclosure on file
Robert H. Scannevin, PhD No disclosure on file
Paul T. Twydell, DO, FAAN Dr. Twydell has received publishing royalties from a publication relating to health care.
Pankaj D. Mehta, PhD No disclosure on file
Omar Butt, MD No disclosure on file
Tanzil Rahman No disclosure on file
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Bernard M. Uitdehaag, MD, PhD, FAAN Dr. Uitdehaag has nothing to disclose.
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
David Geldmacher, MD Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Premier, Inc. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Ihtsham Haq, MD, FAAN The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
David S. Zee, MD Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Ali Bozorg, MD Dr. Bozorg has received personal compensation for serving as an employee of UCB Biosciences. Dr. Bozorg has stock in UCB.
Nathalie Jette, MD, MSc, FRCPC, FAAN Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Miguel Ulla, MD, PhD No disclosure on file
Laurence M. Viollet, PhD No disclosure on file
Moran Hillel No disclosure on file
Sriram Ramgopal No disclosure on file
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Antonio Federico, MD, Prof No disclosure on file
Alexandre Kreisler No disclosure on file
Kamakshi Lakshminarayan, MD, PhD Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Jeremie Pariente No disclosure on file
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Wojciech Kozubski, MD, PhD No disclosure on file
Alexandru C. Barboi, MD Dr. Barboi has nothing to disclose.
Sean Goretzke, MD Dr. Goretzke has nothing to disclose.
Deepa Malaiyandi, MD Dr. Malaiyandi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Journal Critical Care Clinics.
Pamela Federighi No disclosure on file
Soma S. Ray Soma S. Ray has received personal compensation for serving as an employee of Dyne Therapeutics. Soma S. Ray has stock in Dyne Therapeutics.
Kira Leishear No disclosure on file
Leonardo Triggiani No disclosure on file
Spencer Moore No disclosure on file
Nancy Fischbein, MD Dr. Fischbein has received publishing royalties from a publication relating to health care.
Pornpimol Anprasertporn, MD No disclosure on file
Adrian Specogna No disclosure on file
Joslyn Woodard No disclosure on file
Gloria Diaz-Medina, MD No disclosure on file
Jonathan Tran No disclosure on file
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Manoel J. Teixeira, MD No disclosure on file
William Langley No disclosure on file
Marc Bigaud Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma.
Kyle Smoot, MD, FAAN Dr. Smoot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Smoot has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Smoot has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Smoot has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMDSerono. Dr. Smoot has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Smoot has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Smoot has received research support from Genzyme. The institution of Dr. Smoot has received research support from EMDSerono. The institution of Dr. Smoot has received research support from Genentech.
Carlos R. Gordon, MD No disclosure on file
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN Dr. Von Glehn Silva has nothing to disclose.
Jennifer L. Mulbury, MD No disclosure on file
Catherine Maurice, MD No disclosure on file
Erkingul Shugaiv, MD No disclosure on file
Ivan Adamec Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Sathyanath Rajasekharan, PhD No disclosure on file
Benito P. Damasceno, MD, PhD No disclosure on file
Azza Ismail, MBBS, PhD, MRCP No disclosure on file
Dimitrios Arkilo, MD Dr. Arkilo has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Arkilo has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Arkilo has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. An immediate family member of Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. An immediate family member of Dr. Arkilo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Arkilo has stock in Takeda Pharmaceuticals. Dr. Arkilo has stock in Acadia Pharmaceuticals. Dr. Arkilo has stock in Sage Therapeutics.
Ann Ligocki No disclosure on file
Osman Mir, MD No disclosure on file
Daniel Anthony, PhD, MA Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK.
Lindsay N. Alfano, PT Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Omar Malik, MD No disclosure on file
Shreyansh Shah, MD No disclosure on file
John Tzartos, MD No disclosure on file
Letizia Panicari, MD No disclosure on file
Anne Cromer No disclosure on file
Philipp Albrecht, PhD Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Massimiliano Cristofanilli, PhD No disclosure on file
Gilad Yahalom No disclosure on file
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Michael Volkert No disclosure on file
Laury Chamelian No disclosure on file
Maarten Bot No disclosure on file
Edwin J. Landaker, MD No disclosure on file
Brianne Bettcher No disclosure on file
Jon B. Toledo No disclosure on file
Tereza Gabelic No disclosure on file
Yusei Miyazaki, MD, PhD No disclosure on file
Anna Fronda No disclosure on file
Donald Lee No disclosure on file
David Schaller No disclosure on file
Deepali Y. Jain, MD, MBBS Dr. Jain has nothing to disclose.
Ingrid Kockum No disclosure on file
Lauren Brandes, MD Dr. Brandes has nothing to disclose.
Tamar Kassierer No disclosure on file
Diego Torres-Russotto, MD, FAAN Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Meena Subramanyam, PhD No disclosure on file
Nicolas Seneca No disclosure on file
Rana R. Said, MD, FAAN Dr. Said has nothing to disclose.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Pavle Repovic, MD, PhD Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyersSquibb. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Repovic has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Repovic has received research support from Genentech. The institution of Dr. Repovic has received research support from Biogen.
Eddie Jones, BA Eddie Jones, BA has nothing to disclose.
Catherine Lubetzki Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Gerald P. Novak, MD No disclosure on file
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Heather Lau, MD Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Michael Eller, MD No disclosure on file
Luke J. Canham, MBBS, BSc, MRCP No disclosure on file
Bailey Xiao No disclosure on file
John Sekab No disclosure on file
Patty Riley, RN No disclosure on file
Peter Fuhr, MD, FAAN The institution of Dr. Fuhr has received research support from Roche.
Myassar Zarif Myassar Zarif has nothing to disclose.
Arnfin Bergmann Dr. Bergmann has nothing to disclose.
Annette Okai, MD, FAAN Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics.
Roger G. Mills, MD No disclosure on file
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Erik V. Burton, MD Dr. Burton has nothing to disclose.
Timothy J. Turner Timothy J. Turner has received personal compensation for serving as an employee of Sanofi. Timothy J. Turner has stock in Sanofi. Timothy J. Turner has received intellectual property interests from a discovery or technology relating to health care.
Darren M. Stam, PharmD No disclosure on file
Ali-Frederic Ben-Amor, PhD No disclosure on file
Eli Silber, MD Dr. Silber has nothing to disclose.
Bart Van Wijmeersch, MD, PhD Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Ken Liu No disclosure on file
Kelli A. Herrlinger No disclosure on file
Harold Moses, MD No disclosure on file
Gwendoline Shang No disclosure on file
Elisabetta Verdun Di Cantogno, MD Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.
Steven J. Cavalier, MD, FAAN No disclosure on file
Hideki Garren, MD, PhD Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Lakshmanan Suresh No disclosure on file
Tanmoy Ganguly No disclosure on file
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Donna L. Masterman, MD Dr. Masterman has received personal compensation for serving as an employee of Prothena Biosciences . Dr. Masterman has stock in Prothena Biosciences.
Roberto D. Rey, MD Dr. Rey has nothing to disclose.
Shinji Okitsu No disclosure on file
Paulo P. Fontoura, MD, PhD, FAAN Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Nadia Tenenbaum, MD Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Benedikt Schoser Benedikt Schoser has received personal compensation for serving as an employee of Alexion. Benedikt Schoser has received personal compensation for serving as an employee of Argenx. Benedikt Schoser has received personal compensation for serving as an employee of Amicus. Benedikt Schoser has received personal compensation for serving as an employee of Astellas. Benedikt Schoser has received personal compensation for serving as an employee of Denali. Benedikt Schoser has received personal compensation for serving as an employee of Avidity . Benedikt Schoser has received personal compensation for serving as an employee of Sanofi. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astellas. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kedrion.
Valeria Ramaglia No disclosure on file
Erik P. Pioro, MD, DPhil, FAAN Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Luca Massacesi The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
Darcy Krueger, MD Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
John T. Slevin, MD, FAAN Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
William J. Herring, MD, PhD No disclosure on file
Luisa H. Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Mathias Maurer, MD No disclosure on file
Michael Lang No disclosure on file
Goeril Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of Novartis.
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Alex Bennett, PhD, MA No disclosure on file
Alberto Esquenazi, MD Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Teresa M. Mangin, MD, FAAN Dr. Mangin has nothing to disclose.
Jeyaraj D. Pandian, MD, DM Dr. Pandian has nothing to disclose.
Igor J. Koralnik, MD, FAAN Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
Ingo Kleiter No disclosure on file
Julia Tsai No disclosure on file
Jette Lautrup Frederiksen Battisti, MD No disclosure on file
Matthew W. Cravets No disclosure on file
Huw R. Morris, MD, PhD Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group chair with MSBase Foundation that is relevant to AAN interests or activities.
Alessandra Lugaresi, MD Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Loren D. Pena No disclosure on file
Björn Tackenberg, MD, FAAN Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Tatiana Sidorenko, MD, PhD Dr. Sidorenko has received personal compensation for serving as an employee of Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical company of Johnson&Johnson. Dr. Sidorenko has stock in Johnson&Johnson.
Radek Ampapa, MD Dr. Ampapa has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Ampapa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzym. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
James C. Cloyd, PharmD No disclosure on file
Luciano Deotto, MD No disclosure on file
Jordan S. Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Peter Aupperle No disclosure on file
Jimmy A. Schiemann No disclosure on file
Annette Sauter, PhD Dr. Sauter has received personal compensation for serving as an employee of F.Hoffmann-La Roche .
Lawrence Hewitt, PhD No disclosure on file
Jonas Dorn No disclosure on file
Holger Albrecht No disclosure on file
Welton O'Neal, Jr., PharmD No disclosure on file
Christian Cornelissen No disclosure on file
Huy Nguyen No disclosure on file
Alexander Niyazov No disclosure on file
Victoria Barghout, PhD No disclosure on file
Gorana Capkun No disclosure on file
Anja Thormann, MD, PhD No disclosure on file
Ilan Blatt No disclosure on file
Elizabeth Hur, PhD Dr. Hur has received personal compensation for serving as an employee of Averitas Pharma.
Peter McCroskery No disclosure on file
Lynn Davenport No disclosure on file
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Claudia Prada No disclosure on file
Mindl M. Weingarten, PharmD Dr. Weingarten has received personal compensation for serving as an employee of SK Life Science.
Pietro Osvaldo Luigi Annovazzi No disclosure on file
Gerry Rowse No disclosure on file
Cameron Brennan Cameron Brennan has nothing to disclose.